7-Week Integrative Oncology Program | Now Accepting New Patients

What is the history of Lyme Disease?

Lyme disease spirochete - Lyme disease

Although it wouldn’t have a name or known causative agent for nearly one hundred years, Lyme disease research dates back to 1883 when a German physician, Alfred Buchwald, recorded serious deterioration of skin tissue called acrodermatitis chronica atrophicans (ACA). We now recognize ACA as a classic symptom of late-stage European Lyme disease.

In 1908, when Swedish dermatologist Arvid Afzelius first described the classic Lyme-related bullseye rash, erythema migrans (EM), he suspected it may have resulted from a tick bite but couldn’t prove it. Just over a decade later, the first case of neurologic Lyme (Lyme neuroborreliosis) was reported by Garin and Bujadoux. Then, in 1940, similar cases of nerve pain radiating from the spine after tick bites were reported in Germany by Bannwarth, and the condition was recognized as Garin–Bujadoux–Bannwarth syndrome.

The name “Lyme disease” comes from the town of Lyme, Connecticut, where it was first described as a separate illness in 1975 when a group of 51 children and adults reported arthritis-like symptoms, including pain and swelling in large joints, headaches, fever, weakness, skin rash, and fatigue. They coined the condition Lyme but didn’t know the cause.

Several years later in 1981, scientist Willy Burgdorfer discovered a new corkscrew-shaped bacterium, a spirochete, in the gut of deer ticks while studying rocky mountain spotted fever. This new spirochete, which was called Borrelia burgdorferi after Burgdorfer, was determined to be the causative agent in Lyme disease.

To learn more about Lyme Disease treatment in Scottsdale, Arizona at Brio-medical, sign up for a free treatment consultation today with a patient care coordinator.

Meet the Author

Dr. Nathan Goodyear, MD, MDH, ABAARM, is a natural, holistic, and integrative expert in the cancer field. He is the medical director at Brio Medical, a holistic, integrative cancer healing center in Scottsdale, Arizona. Dr. Goodyear received his Bachelor of Arts from Louisiana Tech University and his Doctor of Medicine from LSU Health Sciences Center. He is Board Certified in Obstetrics and Gynecology and served as the Chief Resident in Obstetrics and Gynecology at the University of Tennessee. Dr. Goodyear is a Fellow in Functional and Regenerative Medicine, is a medical Advisor for NEO7 Bioscience and has been named as the President of the North American Society of Laser Therapy Applications (NASLTA).

Related Posts

Ozone non-invasive cancer therapy

Ozone Non-Invasive Cancer Therapy Explained

By Dr. Nathan Goodyear, MD, MDH, ABAARM | January 5, 2024

Welcome to our comprehensive guide on ozone non-invasive cancer therapy. In this article, we will explore the potential benefits, the lack of human studies, and […]

Cancer treatments besides chemo

Exploring Cancer Treatments Beyond Chemo Options

By Dr. Nathan Goodyear, MD, MDH, ABAARM | January 5, 2024

Chemotherapy has long been the standard treatment for cancer, but its efficacy comes with a cost – severe side effects that can significantly impact a […]

Curcumin transdermal skin cancer

Curcumin Transdermal Patch for Skin Cancer Relief

By Dr. Nathan Goodyear, MD, MDH, ABAARM | January 3, 2024

At Our Wellness Center, we are dedicated to providing innovative and effective solutions for skin cancer treatment. In recent years, curcumin, the active component of […]

Vitamin c oral supplement non-hodgkin's lymphoma

Vitamin C Oral Supplement & Non-Hodgkin’s Lymphoma Care

By Dr. Nathan Goodyear, MD, MDH, ABAARM | January 3, 2024

Vitamin C is a potential oral supplement for Non-Hodgkin’s Lymphoma patients to support standard treatments. Studies have shown that vitamin C has various therapeutic effects […]

Resveratrol integrative cancer support

Resveratrol Integrative Cancer Support Insights

By Dr. Nathan Goodyear, MD, MDH, ABAARM | January 3, 2024

Welcome to our comprehensive guide on resveratrol integrative cancer support. In this article, we will explore the potential benefits and limitations of resveratrol, a polyphenolic […]

Red light therapy cellular function malignant brain tumor

Exploring Red Light Therapy for Brain Tumors

By Dr. Nathan Goodyear, MD, MDH, ABAARM | January 3, 2024

At the intersection of cutting-edge technology and medical innovation, red light therapy is emerging as a potential treatment for brain tumors. By harnessing the power […]

Posted in

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top